Rationale and Design of the Aldosterone Targeted NeuroHormonal CombinEd with Natriuresis TherApy in Heart Failure (ATHENA-HF) Trial

While therapy with mineralocorticoid receptor antagonists (MRA) is recommended for patients with chronic heart failure (HF) with reduced ejection fraction and in post-infarction HF, it has not been studied well in acute HF (AHF) despite being commonly used in this setting. At high doses, MRA therapy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JACC Heart Fail
Prif Awduron: Butler, Javed, Hernandez, Adrian F., Anstrom, Kevin J., Kalogeropoulos, Andreas, Redfield, Margaret M., Konstam, Marvin A., Wilson Tang, W. H., Felker, G. Michael, Shah, Monica R., Braunwald, Eugene
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010507/
https://ncbi.nlm.nih.gov/pubmed/27522631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2016.06.003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg